Atlas Trials

ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment

Clinical trial NCT02917629 · TERMINATED

Trial details

NCT number
NCT02917629
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Oral Cavity NeoplasmOropharyngeal NeoplasmStage 0 Oral Cavity Squamous Cell Carcinoma American Joint Committee on Cancer (AJCC) v6 and v7Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7Stage I Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7Stage I Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7Stage II Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7
Start date
2018-05-31
Primary completion
2019-08-28
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.